The Joint Corp. (NASDAQ:JYNT – Get Free Report) major shareholder Charles Jobson acquired 10,396 shares of the stock in a transaction that occurred on Wednesday, November 18th. The stock was acquired at an average cost of $6.65 per share, with a total value of $69,133.40. Following the completion of the purchase, the insider owned 2,046,467 shares of the company’s stock, valued at $13,609,005.55. This trade represents a 0.51% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Joint Trading Down 3.2%
Shares of JYNT traded down $0.21 during mid-day trading on Thursday, hitting $6.43. The company’s stock had a trading volume of 107,906 shares, compared to its average volume of 80,904. The firm has a market capitalization of $88.10 million, a price-to-earnings ratio of 32.18 and a beta of 1.16. The Joint Corp. has a 52-week low of $6.42 and a 52-week high of $10.67. The company’s 50-day moving average is $7.41 and its 200-day moving average is $8.41.
Joint (NASDAQ:JYNT – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Joint had a net margin of 4.81% and a return on equity of 22.11%. The business had revenue of $13.55 million during the quarter, compared to analyst estimates of $14.85 million. As a group, sell-side analysts predict that The Joint Corp. will post 0.31 earnings per share for the current fiscal year.
Analysts Set New Price Targets
JYNT has been the topic of several recent analyst reports. Weiss Ratings upgraded shares of Joint from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, November 11th. B. Riley Financial reduced their price target on Joint from $9.00 to $8.00 and set a “neutral” rating for the company in a research report on Monday, November 9th. Finally, Wall Street Zen downgraded Joint from a “buy” rating to a “hold” rating in a report on Saturday, November 14th. Two research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Reduce” and an average price target of $8.00.
Check Out Our Latest Analysis on Joint
Hedge Funds Weigh In On Joint
Large investors have recently bought and sold shares of the business. Marshall Wace LLP boosted its position in Joint by 372.2% during the third quarter. Marshall Wace LLP now owns 251,089 shares of the company’s stock worth $1,858,000 after purchasing an additional 197,916 shares in the last quarter. R Squared Ltd increased its position in shares of Joint by 40.3% in the third quarter. R Squared Ltd now owns 14,910 shares of the company’s stock valued at $110,000 after buying an additional 4,284 shares in the last quarter. Skylands Capital LLC increased its position in shares of Joint by 5.6% in the third quarter. Skylands Capital LLC now owns 946,045 shares of the company’s stock valued at $7,001,000 after buying an additional 50,473 shares in the last quarter. Squarepoint Ops LLC raised its stake in shares of Joint by 35.5% during the 2nd quarter. Squarepoint Ops LLC now owns 105,467 shares of the company’s stock worth $926,000 after buying an additional 27,633 shares during the period. Finally, Susquehanna International Group LLP raised its stake in shares of Joint by 161.3% during the 2nd quarter. Susquehanna International Group LLP now owns 43,138 shares of the company’s stock worth $379,000 after buying an additional 26,626 shares during the period. Institutional investors and hedge funds own 76.88% of the company’s stock.
About Joint
The Joint Corp. operates and franchises The Joint Chiropractic, a network of clinics providing chiropractic care in the United States. Its clinics offer services such as spinal adjustments and other chiropractic treatments focused on musculoskeletal health and wellness. The company’s business model emphasizes convenient access to care, with options that include walk-in visits and recurring membership plans. The Joint Corp. was established in 2010 and is headquartered in Scottsdale, Arizona.
Read More
- Five stocks we like better than Joint
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.
